Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in Northern China

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 54, Issue 2, 2009, Pages 88-94

  Zhao, Ying ^a   Zhang, Weiyuan ^a   Duan, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Actinomycin D; Gestational trophoblastic neoplasia; Mole

Indexed keywords

BLEOMYCIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER REGRESSION; CHEMOTHERAPY; CHINA; DIARRHEA; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; METASTASIS; MOUTH ULCER; PARITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TROPHOBLASTIC TUMOR; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHINA; COHORT STUDIES; DACTINOMYCIN; FEMALE; FLUOROURACIL; HUMANS; HYDATIDIFORM MOLE; NEOPLASM STAGING; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR, PLACENTAL SITE; YOUNG ADULT;

EID: 62849117565     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kohorn EI: The new FIGO staging and risk factor scoring system for GTD: Description and critical assessment. Int J Gynecol Cancer 2000;11:73-77
2. Dainty LA, Winter WE, Maxwell GL: The clinical behavior of placental site trophoblastic tumor and contemporary methods of management. Clin Obstet Gynecol 2003;46:607-611
3. Cortes-Charry R, Lina M, Garcia-Barriola V, et al: Gestational trophoblastic neoplasia clinical trends in 8 years at Hospital Universitario de Caracas. J Reprod Med 2006;51:888-891
4. Charkrabarti BK, Monda NR, Chatterjee T: Gestational trophoblastic tumor at a tertiary level cancer center. J Reprod Med 2006;51:875-878
5. Yang J, Xiang Y, Wan X, et al: Recurrent gestational trophoblastic tumor: Management and risk factors for recurrence. Gynecol Oncol 2006;103:587-590
6. Song HL, Wan XR: Gynecology Oncology of QiaozhiLin. Beijing, People's Health Press, 2006, pp 757-760
7. Song HZ, Wu PC: Hydatidiform mole in China: A preliminary report of incidence on more than three million women. WHO Bull 1987;65:507-511
8. Lurain JR, Nejad B: Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97: 618-623
9. Cagavan MS, Gacoba MC: Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: Treatment outcomes and toxicity. J Reprod Med 2006;51:907-918
10. Paradinas FJ: The diagnosis and prognosis of molar pregnancy: The experience of the National Referral Centre in London. Int J Gynecol Obstet (Suppl 1) 1998;60:857-564
11. Morrow CP, Kletzky OA, Disaia PJ, et al: Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 1977;128:424-00
12. Berkowitz RS, Goldstein DP: Chorionic tumors. N Engl J Med 1996;335:1740-1748
13. Growdon WB, Wolfberg AJ, Feltmate CM, et al: Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med 2006;51:871-874
14. Berkowitz RS, Goldstein DP, Bernstein MR: Natural history of partial molar pregnancy. Obstet Gynecol 1985;66:677-681
15. Feltmate CM, Growdon WB, Wolfberg AJ, et al: Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 2006;51:902-906